Akira Iyoda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Akira Iyoda has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Kiyoshi Shibuya
Department of Thoracic Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan
4 shared publications - Kazuhiro Yasufuku
Division of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada
3 shared publications Kenzo Hiroshima
Chiba University
3 shared publicationsMakoto Suzuki
3 shared publications- Takehiko Fujisawa
Chiba Foundation for Health Promotion and Disease Prevention
3 shared publications Toshihiko Iizasa
3 shared publications
Latest Publications
- 1 July 2008
- Published by Springer Nature in General Thoracic and Cardiovascular Surgery
- Vol. 56 (7) , 354-356
Successful management of postoperative acute respiratory distress syndrome in a patient with lung cancer
Acute respiratory distress syndrome after pulmonary resection for lung cancer frequently has a lethal outcome. Treatment with a combination therapy of neutrophil elastase inhibitor and steroid administration was used to achieve good control, without impairing lung function, in a patient with postoperative acute respiratory distress syndrome. A 74-year-old man was diagnosed with lung cancer and referred to the outpatient department of Chiba University Hospital with double primary lung cancers located in the right upper lobe that were staged at T2N0M0 (stage IB). He underwent right upper lobectomy with hilar and mediastinal lymph node dissection. After 10 postoperative days, he had acute respiratory distress syndrome. He was given a corticosteroid and a neutrophil elastase inhibitor, which resulted in rapid improvement without lung dysfunction.
- 1 July 2008
- Published by Springer Nature in General Thoracic and Cardiovascular Surgery
- Vol. 56 (7) , 354-356
Successful management of postoperative acute respiratory distress syndrome in a patient with lung cancer
Acute respiratory distress syndrome after pulmonary resection for lung cancer frequently has a lethal outcome. Treatment with a combination therapy of neutrophil elastase inhibitor and steroid administration was used to achieve good control, without impairing lung function, in a patient with postoperative acute respiratory distress syndrome. A 74-year-old man was diagnosed with lung cancer and referred to the outpatient department of Chiba University Hospital with double primary lung cancers located in the right upper lobe that were staged at T2N0M0 (stage IB). He underwent right upper lobectomy with hilar and mediastinal lymph node dissection. After 10 postoperative days, he had acute respiratory distress syndrome. He was given a corticosteroid and a neutrophil elastase inhibitor, which resulted in rapid improvement without lung dysfunction.
- 1 August 2007
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 2 (8) , S790
P3-260: Chronic obstructive pulmonary disease decreases postoperative survival due to higher recurrence in male patients with stage IA lung cancer
- 1 August 2007
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 2 (8) , S790
P3-260: Chronic obstructive pulmonary disease decreases postoperative survival due to higher recurrence in male patients with stage IA lung cancer
- 1 August 2007
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 84 (2) , 702-707
Pulmonary Large Cell Neuroendocrine Carcinoma: Its Place in the Spectrum of Pulmonary Carcinoma
- 1 August 2007
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 84 (2) , 702-707
Pulmonary Large Cell Neuroendocrine Carcinoma: Its Place in the Spectrum of Pulmonary Carcinoma
- 1 August 2006
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 132 (2) , 312-315
Prognostic impact of large cell neuroendocrine histology in patients with pathologic stage Ia pulmonary non–small cell carcinoma
- 1 August 2006
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 132 (2) , 312-315
Prognostic impact of large cell neuroendocrine histology in patients with pathologic stage Ia pulmonary non–small cell carcinoma
- Open Access
- 1 June 2006
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 29 (6) , 908-913
Does perioperative high-dose prednisolone have clinical benefits for generalized myasthenia gravis?
Myasthenia gravis (MG) is an autoimmune disorder that results from dysfunction of the post-synaptic acetylcholine receptor (AchR), which may be due to reduced receptor density, increased turnover, or antibodies (AchR-Ab). Immunosuppressant therapies have been shown to suppress the destructive activity of AchR-Ab at neuromuscular junctions. Anticholinesterase inhibitors are used as a first-line medical therapy, and corticosteroids are used for patients with moderate to severe symptoms. However, anticholinesterase medications, such as pyridostigmine, do not prevent the AchR-Ab-mediated destruction of neuromuscular junctions. Furthermore, long-term use of anticholinesterases can reduce AchR responses due to the destruction of AchR, leading to increased anticholinesterase doses [1] that can suppress cardiac function [2].
- 1 June 2006
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 29 (6) , 908-913
Open AccessDoes perioperative high-dose prednisolone have clinical benefits for generalized myasthenia gravis?
Myasthenia gravis (MG) is an autoimmune disorder that results from dysfunction of the post-synaptic acetylcholine receptor (AchR), which may be due to reduced receptor density, increased turnover, or antibodies (AchR-Ab). Immunosuppressant therapies have been shown to suppress the destructive activity of AchR-Ab at neuromuscular junctions. Anticholinesterase inhibitors are used as a first-line medical therapy, and corticosteroids are used for patients with moderate to severe symptoms. However, anticholinesterase medications, such as pyridostigmine, do not prevent the AchR-Ab-mediated destruction of neuromuscular junctions. Furthermore, long-term use of anticholinesterases can reduce AchR responses due to the destruction of AchR, leading to increased anticholinesterase doses [1] that can suppress cardiac function [2].
- 1 January 2005
- Published by Japan Lung Cancer Society in Haigan
- Vol. 45 (3) , 241-247
Diffuse Malignant Mesothelioma of the Pleura-A Clinical Study of 51 Cases from a Multi-institutional Study Group-
- 1 January 2005
- Published by Japan Lung Cancer Society in Haigan
- Vol. 45 (3) , 241-247
Diffuse Malignant Mesothelioma of the Pleura-A Clinical Study of 51 Cases from a Multi-institutional Study Group-
- 1 January 2005
- Published by Japan Lung Cancer Society in Haigan
- Vol. 45 (3) , 221-227
Significance of Expression of Collagen XVIII as an Important Prognostic Factor in Non-Small Cell Lung Carcinoma
目的. XVIII型コラーゲンは, 血管新生抑制因子の一つであるエンドスタチンの前駆物質であり, 血管および上皮基底膜を構成する細胞外マトリックス蛋白の構成成分である. 本研究は非小細胞肺癌におけるXVIII型コラーゲン発現の予後因子としての重要性を明らかにすることを目的とした. 対象と方法. 1994~2000年に切除された非小細胞肺癌306例を対象とした. 男女比は215:91, 年齢は31~85歳 (平均64.8±9.8歳). 扁平上皮癌114例, 腺癌179例, 大細胞癌13例. 術後病期I期130例, II期47例, III期113例, IV期16例であった. 抗XVIII型コラーゲン抗体にて免疫染色を行い, 臨床的因子 (年齢, 性別, 組織型, T因子, N因子, 術後病期) との相関ならびに予後を統計学的に解析した. 結果. 抗XVIII型コラーゲン抗体による切除標本の染色結果は, 陰性92例, 陽性119例ならびに強陽性95例であった. 全体の5年生存率は陰性例70.4%, 陽性例56.5%ならびに強陽性例40.3%で, 強陽性群, 陽性群ではいずれも陰性例に比べ有意に予後不良であった (P<0.0001). 多変量解析でも, 免疫染色によるXVIII型コラーゲン発現は独立した予後因子として選択された. 結論. 非小細胞肺癌におけるXVIII型コラーゲンの発現は69.9%の症例に認められ, XVIII型コラーゲンの発現は予後を強く決定づける因子と考えられた.
- 1 January 2005
- Published by Japan Lung Cancer Society in Haigan
- Vol. 45 (3) , 221-227
Significance of Expression of Collagen XVIII as an Important Prognostic Factor in Non-Small Cell Lung Carcinoma
目的. XVIII型コラーゲンは, 血管新生抑制因子の一つであるエンドスタチンの前駆物質であり, 血管および上皮基底膜を構成する細胞外マトリックス蛋白の構成成分である. 本研究は非小細胞肺癌におけるXVIII型コラーゲン発現の予後因子としての重要性を明らかにすることを目的とした. 対象と方法. 1994~2000年に切除された非小細胞肺癌306例を対象とした. 男女比は215:91, 年齢は31~85歳 (平均64.8±9.8歳). 扁平上皮癌114例, 腺癌179例, 大細胞癌13例. 術後病期I期130例, II期47例, III期113例, IV期16例であった. 抗XVIII型コラーゲン抗体にて免疫染色を行い, 臨床的因子 (年齢, 性別, 組織型, T因子, N因子, 術後病期) との相関ならびに予後を統計学的に解析した. 結果. 抗XVIII型コラーゲン抗体による切除標本の染色結果は, 陰性92例, 陽性119例ならびに強陽性95例であった. 全体の5年生存率は陰性例70.4%, 陽性例56.5%ならびに強陽性例40.3%で, 強陽性群, 陽性群ではいずれも陰性例に比べ有意に予後不良であった (P<0.0001). 多変量解析でも, 免疫染色によるXVIII型コラーゲン発現は独立した予後因子として選択された. 結論. 非小細胞肺癌におけるXVIII型コラーゲンの発現は69.9%の症例に認められ, XVIII型コラーゲンの発現は予後を強く決定づける因子と考えられた.
- 1 October 2004
- Vol. 10 (5) , 293-6
Dramatic improvement of respiratory condition after lobectomy for localized bullous emphysema.
A case of dramatic improvement of respiratory function after lobectomy for bullous emphysema with severe hyperinflation of the left lower lobe was reported. A 72-year-old gentleman was admitted to our hospital due to increasing dyspnea with Hugh-Johns class V. His chest X-ray and computed tomography revealed a hyperinflation of the left lower lobe. Despite medication and respiratory rehabilitation, blood gas analysis showed hypercapnia and his symptoms had been progressing. Bronchofiberscopy revealed that the left lower lobe bronchi opened on inspiration and closed on expiration. Since complete destruction of the lower lobe due to air trapping was thought to be the cause of localized hyperinflation and the compression of left upper lobe, left lower lobectomy was performed. His dyspnea immediately disappeared and the respiratory function improved dramatically. We concluded that lobectomy could be considered as one of surgical options in case of complete lobar destruction in emphysema patients.
- 1 October 2004
- Vol. 10 (5) , 293-6
Dramatic improvement of respiratory condition after lobectomy for localized bullous emphysema.
A case of dramatic improvement of respiratory function after lobectomy for bullous emphysema with severe hyperinflation of the left lower lobe was reported. A 72-year-old gentleman was admitted to our hospital due to increasing dyspnea with Hugh-Johns class V. His chest X-ray and computed tomography revealed a hyperinflation of the left lower lobe. Despite medication and respiratory rehabilitation, blood gas analysis showed hypercapnia and his symptoms had been progressing. Bronchofiberscopy revealed that the left lower lobe bronchi opened on inspiration and closed on expiration. Since complete destruction of the lower lobe due to air trapping was thought to be the cause of localized hyperinflation and the compression of left upper lobe, left lower lobectomy was performed. His dyspnea immediately disappeared and the respiratory function improved dramatically. We concluded that lobectomy could be considered as one of surgical options in case of complete lobar destruction in emphysema patients.